
(GalNAc)3-CPT is a glycoconjugate prodrug that targets the asialoglyco-protein рецептор (ASGR) overexpressed on hepatocytes. (GalNAc)3-CPT exhibits significant antitumor activity (IC50 value of 3.07 μM in HepG2 cells) by activating the cGAS-STING pathway and promoting CD8+ T клетка infiltration into tumors, thereby inducing tumor клетка apoptosis.
(GalNAc)3-CPT is a glycoconjugate prodrug that targets the asialoglyco-protein receptor (ASGR) overexpressed on hepatocytes. (GalNAc)3-CPT exhibits significant antitumor activity (IC50 value of 3.07 μM in HepG2 cells) by activating the cGAS-STING pathway and promoting CD8+ T cell infiltration into tumors, thereby inducing tumor cell apoptosis.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.